Brain tumor radiation study using AI planning
Part of Cancer clinical trials.
This trial tests a new way to plan radiation therapy for brain tumors (gliomas) using artificial intelligence. It aims to make treatment more precise and personalized for people with either aggressive (GBM) or slower-growing (IDH-mutant) gliomas.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a brain tumor called a diffuse glioma (confirmed by biopsy).
- You are between 18 and 70 years old.
- You are well enough to care for yourself (performance score of 60 or higher).
- Your tumor type is either an IDH-negative glioblastoma or an IDH-mutant glioma that needs radiation.
- You have not had radiation to the head, neck, or brain before, and are not currently on chemotherapy.
- You do not have multiple separate tumors or other conditions that prevent having MRI or PET scans during treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using artificial intelligence to plan radiation therapy can improve treatment for people with a newly diagnosed type of brain tumor called glioblastoma. If you qualify, you would receive radiation therapy planned with the help of a computer program.
This trial tests whether using advanced MRI scans before radiation therapy can help doctors target the tumor more precisely and possibly improve outcomes for people with glioblastoma. It aims to make radiation treatment more personalized.
This trial tests a special form of radiation therapy for older or frail adults with a type of brain tumor called glioma. The radiation is placed directly in the area where the tumor was removed during surgery, which may help prevent the tumor from growing back.
This trial uses advanced imaging to help surgeons remove as much of a malignant brain tumor as safely possible. It may be a good fit if you have a new diagnosis of glioblastoma or a certain astrocytoma and are healthy enough for surgery.
This trial tests a new type of targeted radiation therapy for people with high-grade glioma (grade 3 or 4) that has not progressed after standard treatment. The therapy uses a radioactive substance attached to a protein that targets tumor cells, aiming to deliver radiation directly to the cancer.
This trial tests whether adding a precise, MRI-guided radiation treatment to tumor-treating electric fields (TTFields) can help people with recurrent glioblastoma. You may qualify if your tumor has come back 1 to 3 times after standard therapy and you haven't had certain prior treatments.
Hear when a new Diffuse Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.